CynergisTek (CTEK) Tops Q1 EPS by 6c

CynergisTek (NYSE: CTEK) reported Q1 EPS of ($0.08), $0.06 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.23 million.

“Budgets are returning, pricing is improving, and pre-sold revenue continues to grow coming off the momentum started in Q4,” said Caleb Barlow, President and CEO of CynergisTek, Inc. Mr. Barlow goes on to note, “On-going, high-profile ransomware attacks on U.S. Critical infrastructure including the incident at Scripps Health and the shutdown at the Colonial Pipeline are resulting in increased awareness in the c-suite that investment in prevention and preparation is far less costly than remediating an attack.”

For earnings history and earnings-related data on CynergisTek (CTEK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c